1. M.A. Kass, D.K. Heuer, E.J. Higginbotham, C.A. Johnson, J.L. Keltner, J.P. Miller, R.K. Garrish 2nd, W.R. Wilson, M.O. Gordon, The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 701–713 and 829–830.
2. Neuroprotective properties of a synthetic docosanoid, unoprostone isopropyl: clinical benefits in the treatment of glaucoma;Melamed;Drugs Exp. Clin. Res.,2002
3. Mechanisms of action of unoprostone on trabecular meshwork contractility;Thieme;Invest. Ophthalmol. Vis. Sci.,2001
4. Vasodilatory mechanism of unoprostone isopropyl on isolated rabbit ciliary artery;Yoshitomi;Curr. Eye Res.,2004
5. Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells;Thieme;Ophthalmic Res.,2005